弥散加权成像预测乳腺癌新辅助化疗后腋窝反应
该回顾性研究纳入74例接受新辅助化疗后手术的乳腺癌患者,探讨基于乳腺病灶ADC值增高的原发灶反应能否预测腋窝病理完全缓解。结果显示腋窝完全缓解与雌激素受体阴性、Her2阳性及原发灶反应相关,ADC值增高>0.92×10-3 mm2/s的肿瘤中42.8%出现腋窝完全缓解。结论提示将DWI评估的肿瘤反应纳入模型可改善腋窝反应预测。
要点
- ADC值增高>0.92×10-3 mm2/s提示腋窝完全缓解概率较高。
- 腋窝完全缓解与ER阴性、Her2阳性及原发灶反应相关。
- DWI评估的原发灶反应可辅助预测腋窝病理完全缓解。
核心结论
- 基于DWI的乳腺原发灶反应可帮助预测新辅助化疗后腋窝完全缓解,加入该指标可改善预测模型。
研究设计与样本
- 回顾性研究纳入2015年1月至2020年9月在Lucus Augusti医院接受新辅助化疗后手术的74例乳腺癌患者。
- 采用简单逻辑回归评估与腋窝病理完全缓解相关的因素,包括治疗导致的乳腺肿瘤ADC值变化。
关键影像表现/征象
- 腋窝完全缓解与雌激素受体阴性、Her2阳性及原发灶反应相关。
- 反应者的肿瘤ADC值在新辅助化疗后增高更明显。
诊断标准与关键数值
- 腋窝完全缓解率为31%。
- ADC值增高>0.92×10-3 mm2/s的肿瘤中42.8%(15/35)出现腋窝完全缓解。
- ADC增高低于切off值的乳腺癌中8例(20.5%)治疗后无转移淋巴结(p=0.038)。
临床应用与阅片要点
- 阅片时可关注新辅助化疗前后ADC值变化,辅助预测腋窝病理完全缓解。
- ADC值增高幅度可作为原发灶反应的影像指标之一,纳入腋窝反应评估。
局限性
- 回顾性研究,样本量74例,单中心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to investigate whether the primary tumour response to neoadjuvant chemotherapy (NAC), based on the increase in the ADC-values (apparent diffusion coefficient) within the breast lesion, could help to predict axillary complete response.
METHODS: We retrospectively included 74 patients who were treated with NAC followed by surgery at Lucus Augusti Hospital between January 2015 and September 2020. Simple logistic regression was used to evaluate the factors associated with axillary pathological complete response, including the changes in breast tumour ADC-values due to the treatment.
RESULTS: Axillary complete response was correlated with negative oestrogen receptor status, Her2 positivity and response of primary tumour. It was achieved in 31% of the patients. In addition, the increase in the tumour ADC-values with NAC was higher for responders. Among the tumours that demonstrated an increase in ADC-value >0.92 ×10-3 mm2/s, 42.8% (15/35) showed axillary complete response. Eight (20.5%) breast cancers with an increase in ADC below the cut-off value were found to have no metastatic nodes after treatment (p = 0.038).
CONCLUSION: Our results suggest that the performance of models predicting axillary response to NAC can be improved by adding the tumour response determined also using diffusion-weighted imaging.
ADVANCES IN KNOWLEDGE: For the fist time, we investigate the relation between tumour response to NAC, assessed using diffusion-weighted imaging, and axillary pathologic complete response.
引用
- Graña-López, Pérez-Ramos, Maciñeira, et al. Predicting axillary response to neoadjuvant chemotherapy: the role of diffusion weighted imaging. Br J Radiol. 2021. PMID: 34757835. doi:10.1259/bjr.20210511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。